Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

New consortium to make UK a world leader in AI drug discovery

A new consortium, co-led by NDM researchers, has just been announced, aiming to make the UK a leader in artificial intelligence-driven drug discovery. The ‘OpenBind’ consortium will slash the cost of drug discovery and development by as much as £100 billion.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

Malaria vaccine wins Galien Foundation prize for Best Public Sector Innovation

The R21/Matrix-M malaria vaccine has received the Galien Foundation prize for Best Public Sector Innovation. Members of the Jenner Institute team, Prof Sir Adrian Hill, Mehreen Datoo and Lisa Stockdale were present during the Galien Foundation UK Forum & Awards Ceremony in London on 05 June 2025.

Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures

A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy’s lasting impact.

New research identifies key driver of inflammation in spondyloarthritis

New research identifies key driver of inflammation in spondyloarthritis